Navigation

NICE complies with judge's ruling on judicial review

NICE has today (7 September 2007) published an amended version of its technology appraisal of drugs to treat Alzheimer’s disease to fully comply with the judge’s ruling on the judicial review.  The guidance issued in November 2006 still stands and the drugs continue to be recommended only for people with moderate Alzheimer’s disease.  In line with the judge’s ruling, NICE has clarified how the guidance should be applied to certain groups, including people with learning disabilities and people whose first language is not English.  

This page was last updated: 30 March 2010

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.